Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tumor Necrosis Factor-alpha | 42 | 2020 | 4340 | 3.330 |
Why?
|
Mycobacterium tuberculosis | 13 | 2018 | 1912 | 1.720 |
Why?
|
Lymphotoxin-alpha | 5 | 2020 | 93 | 1.390 |
Why?
|
Tuberculosis, Pulmonary | 9 | 2012 | 830 | 1.280 |
Why?
|
Promoter Regions, Genetic | 30 | 2020 | 5773 | 1.270 |
Why?
|
Tuberculosis | 13 | 2015 | 2016 | 1.040 |
Why?
|
Virus Replication | 7 | 2012 | 2426 | 0.950 |
Why?
|
Monocytes | 10 | 2022 | 2570 | 0.840 |
Why?
|
NFATC Transcription Factors | 12 | 2012 | 390 | 0.820 |
Why?
|
HIV-1 | 12 | 2012 | 6851 | 0.790 |
Why?
|
Gene Expression Regulation | 20 | 2016 | 11856 | 0.780 |
Why?
|
Transcriptional Activation | 10 | 2014 | 1749 | 0.760 |
Why?
|
Antitubercular Agents | 6 | 2018 | 1374 | 0.740 |
Why?
|
Tuberculosis, Multidrug-Resistant | 3 | 2018 | 934 | 0.670 |
Why?
|
Interleukin-10 | 5 | 2005 | 1176 | 0.610 |
Why?
|
Cambodia | 12 | 2015 | 185 | 0.550 |
Why?
|
Transcription Factors | 18 | 2012 | 12099 | 0.540 |
Why?
|
Nuclear Proteins | 10 | 2005 | 5782 | 0.530 |
Why?
|
T-Lymphocytes | 15 | 2015 | 10203 | 0.510 |
Why?
|
Conserved Sequence | 6 | 2020 | 1162 | 0.490 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2020 | 4372 | 0.490 |
Why?
|
Transcription, Genetic | 22 | 2020 | 7571 | 0.480 |
Why?
|
DNA-Binding Proteins | 14 | 2022 | 9566 | 0.480 |
Why?
|
Clonal Anergy | 4 | 2004 | 169 | 0.470 |
Why?
|
Lipopolysaccharides | 8 | 2014 | 2199 | 0.460 |
Why?
|
HIV Infections | 15 | 2018 | 17347 | 0.440 |
Why?
|
Antigens, Differentiation | 2 | 2016 | 918 | 0.440 |
Why?
|
Trans-Activators | 4 | 2006 | 2846 | 0.420 |
Why?
|
Enhancer Elements, Genetic | 6 | 2020 | 1360 | 0.410 |
Why?
|
Interferon-gamma | 5 | 2014 | 3155 | 0.410 |
Why?
|
Base Sequence | 21 | 2014 | 12404 | 0.410 |
Why?
|
HLA-DQ Antigens | 2 | 2006 | 190 | 0.390 |
Why?
|
HIV Long Terminal Repeat | 1 | 2011 | 85 | 0.380 |
Why?
|
Primates | 2 | 2007 | 521 | 0.380 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2011 | 121 | 0.370 |
Why?
|
Gene Expression | 4 | 2020 | 7571 | 0.370 |
Why?
|
Molecular Sequence Data | 20 | 2014 | 17598 | 0.370 |
Why?
|
Acetylation | 4 | 2020 | 1050 | 0.360 |
Why?
|
Adaptive Immunity | 1 | 2015 | 724 | 0.340 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1448 | 0.340 |
Why?
|
Evolution, Molecular | 3 | 2003 | 1882 | 0.330 |
Why?
|
Cyclosporine | 5 | 1995 | 776 | 0.330 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 4 | 2003 | 501 | 0.320 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 575 | 0.310 |
Why?
|
Tuberculin Test | 3 | 2004 | 205 | 0.310 |
Why?
|
Sp1 Transcription Factor | 4 | 2003 | 140 | 0.310 |
Why?
|
Binding Sites | 11 | 2020 | 5988 | 0.300 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 1999 | 585 | 0.300 |
Why?
|
Platyrrhini | 1 | 2007 | 5 | 0.300 |
Why?
|
Phylogeny | 3 | 2007 | 2809 | 0.300 |
Why?
|
Deoxyribonuclease I | 5 | 2011 | 221 | 0.290 |
Why?
|
Cytokines | 7 | 2015 | 7386 | 0.290 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2013 | 976 | 0.280 |
Why?
|
Chromosomes, Mammalian | 1 | 2007 | 147 | 0.280 |
Why?
|
RNA, Messenger | 9 | 2020 | 12747 | 0.270 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1803 | 0.270 |
Why?
|
Terminal Repeat Sequences | 1 | 2006 | 70 | 0.270 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1855 | 0.270 |
Why?
|
Gene Products, tat | 1 | 2006 | 111 | 0.260 |
Why?
|
Cell Line | 17 | 2014 | 15545 | 0.260 |
Why?
|
Histones | 5 | 2020 | 2570 | 0.260 |
Why?
|
Anti-Retroviral Agents | 3 | 2015 | 1784 | 0.250 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2010 | 634 | 0.250 |
Why?
|
Protein Binding | 7 | 2020 | 9297 | 0.240 |
Why?
|
B-Lymphocytes | 7 | 1996 | 4744 | 0.240 |
Why?
|
Genes, Reporter | 6 | 2016 | 1518 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2011 | 8530 | 0.230 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 2 | 2015 | 61 | 0.230 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 1985 | 0.220 |
Why?
|
Epithelial Cells | 1 | 2015 | 3671 | 0.220 |
Why?
|
HLA-B Antigens | 2 | 2001 | 317 | 0.210 |
Why?
|
Superantigens | 2 | 2000 | 126 | 0.210 |
Why?
|
Lymphocyte Activation | 7 | 2015 | 5478 | 0.200 |
Why?
|
Antigens, Bacterial | 2 | 2006 | 1140 | 0.200 |
Why?
|
Epigenesis, Genetic | 2 | 2013 | 3788 | 0.200 |
Why?
|
RNA Interference | 3 | 2006 | 2816 | 0.190 |
Why?
|
Benzoxazines | 2 | 2014 | 316 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2010 | 15920 | 0.190 |
Why?
|
Immunity, Innate | 3 | 2012 | 3044 | 0.190 |
Why?
|
Chromatin | 4 | 2011 | 2946 | 0.190 |
Why?
|
Host-Parasite Interactions | 1 | 2003 | 300 | 0.190 |
Why?
|
Homozygote | 3 | 2006 | 1775 | 0.190 |
Why?
|
Enterotoxins | 2 | 2000 | 365 | 0.180 |
Why?
|
Membrane Proteins | 3 | 2015 | 7851 | 0.180 |
Why?
|
Introns | 1 | 2003 | 968 | 0.180 |
Why?
|
Signal Transduction | 9 | 2015 | 23416 | 0.180 |
Why?
|
Cells, Cultured | 9 | 2015 | 18926 | 0.180 |
Why?
|
Tacrolimus | 2 | 1995 | 736 | 0.170 |
Why?
|
Immediate-Early Proteins | 1 | 2003 | 444 | 0.170 |
Why?
|
HeLa Cells | 4 | 2011 | 3073 | 0.170 |
Why?
|
DNA | 8 | 2011 | 7189 | 0.170 |
Why?
|
Anti-HIV Agents | 4 | 2014 | 4526 | 0.170 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 822 | 0.170 |
Why?
|
Activating Transcription Factor 2 | 4 | 2003 | 44 | 0.160 |
Why?
|
Humans | 70 | 2022 | 761208 | 0.160 |
Why?
|
Community Health Services | 1 | 2004 | 654 | 0.160 |
Why?
|
Macrophages | 4 | 2007 | 5753 | 0.160 |
Why?
|
Receptors, IgG | 1 | 2022 | 558 | 0.160 |
Why?
|
Animals | 27 | 2018 | 168079 | 0.160 |
Why?
|
Cell Transformation, Viral | 2 | 1990 | 526 | 0.150 |
Why?
|
Flow Cytometry | 3 | 2018 | 5871 | 0.150 |
Why?
|
Viremia | 1 | 2001 | 707 | 0.150 |
Why?
|
NF-kappa B | 7 | 2010 | 2475 | 0.150 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 1838 | 0.140 |
Why?
|
Immunologic Memory | 1 | 2004 | 1361 | 0.140 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2006 | 2196 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-ets | 3 | 2003 | 314 | 0.140 |
Why?
|
Image Cytometry | 1 | 2016 | 53 | 0.130 |
Why?
|
Parasitic Diseases | 1 | 1996 | 76 | 0.130 |
Why?
|
Calmodulin-Binding Proteins | 2 | 1994 | 233 | 0.130 |
Why?
|
RNA Polymerase II | 1 | 2020 | 537 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2000 | 2549 | 0.130 |
Why?
|
Antibodies, Bacterial | 1 | 2002 | 1464 | 0.130 |
Why?
|
Polymorphism, Genetic | 3 | 2006 | 4243 | 0.130 |
Why?
|
Interferon Type I | 2 | 1991 | 557 | 0.130 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2011 | 662 | 0.130 |
Why?
|
Phosphoprotein Phosphatases | 2 | 1994 | 328 | 0.130 |
Why?
|
Cell Differentiation | 2 | 2013 | 11509 | 0.130 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1999 | 570 | 0.130 |
Why?
|
Transfection | 7 | 2005 | 5748 | 0.130 |
Why?
|
Toxoplasma | 1 | 2016 | 158 | 0.120 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2014 | 68 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 5 | 2004 | 17897 | 0.120 |
Why?
|
Cell Nucleus | 4 | 2011 | 2881 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 3 | 2003 | 4513 | 0.120 |
Why?
|
Genetic Loci | 2 | 2014 | 2623 | 0.120 |
Why?
|
Mice | 17 | 2012 | 81326 | 0.110 |
Why?
|
Antigens, CD | 3 | 1999 | 4009 | 0.110 |
Why?
|
Shock, Septic | 1 | 2000 | 769 | 0.110 |
Why?
|
Ethiopia | 1 | 2015 | 461 | 0.110 |
Why?
|
Inflammation | 2 | 2022 | 10759 | 0.110 |
Why?
|
Tuberculin | 2 | 2004 | 64 | 0.110 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 344 | 0.110 |
Why?
|
Jurkat Cells | 2 | 2006 | 739 | 0.110 |
Why?
|
Phagocytosis | 2 | 2016 | 1525 | 0.110 |
Why?
|
Parainfluenza Virus 1, Human | 2 | 1991 | 25 | 0.110 |
Why?
|
CREB-Binding Protein | 3 | 2008 | 146 | 0.110 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1991 | 818 | 0.110 |
Why?
|
Endosomes | 1 | 2015 | 518 | 0.100 |
Why?
|
Ionophores | 2 | 2007 | 107 | 0.100 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2012 | 44 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2244 | 0.100 |
Why?
|
Growth Substances | 1 | 1994 | 759 | 0.100 |
Why?
|
BCG Vaccine | 1 | 2015 | 369 | 0.100 |
Why?
|
ets-Domain Protein Elk-1 | 2 | 2003 | 38 | 0.100 |
Why?
|
Herpesvirus 4, Human | 2 | 1995 | 1076 | 0.100 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2009 | 292 | 0.100 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 76 | 0.100 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 577 | 0.100 |
Why?
|
Protein Structure, Tertiary | 3 | 2008 | 3778 | 0.090 |
Why?
|
Protein Transport | 2 | 2015 | 1958 | 0.090 |
Why?
|
Disease Susceptibility | 2 | 2012 | 1791 | 0.090 |
Why?
|
Immunomodulation | 1 | 2015 | 548 | 0.090 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2014 | 621 | 0.090 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2635 | 0.090 |
Why?
|
Receptors, Pattern Recognition | 1 | 2011 | 80 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2004 | 4574 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2014 | 1895 | 0.090 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1992 | 544 | 0.080 |
Why?
|
Genes, Immediate-Early | 1 | 2010 | 102 | 0.080 |
Why?
|
Transcription Factor RelA | 2 | 2007 | 254 | 0.080 |
Why?
|
Leucine Zippers | 2 | 1999 | 116 | 0.080 |
Why?
|
Pongo | 1 | 2007 | 4 | 0.070 |
Why?
|
Hylobates | 1 | 2007 | 13 | 0.070 |
Why?
|
Gorilla gorilla | 1 | 2007 | 29 | 0.070 |
Why?
|
Torture | 1 | 1988 | 67 | 0.070 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 583 | 0.070 |
Why?
|
Hominidae | 1 | 2007 | 67 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1967 | 0.070 |
Why?
|
Gene Frequency | 2 | 2006 | 3603 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2451 | 0.070 |
Why?
|
Vietnam | 1 | 2007 | 406 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2015 | 4243 | 0.070 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 118 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 3 | 2014 | 2569 | 0.060 |
Why?
|
Models, Molecular | 2 | 2006 | 5406 | 0.060 |
Why?
|
Mutation | 6 | 2005 | 30002 | 0.060 |
Why?
|
Acetylcysteine | 1 | 2007 | 260 | 0.060 |
Why?
|
Up-Regulation | 1 | 2014 | 4111 | 0.060 |
Why?
|
Body Weight | 2 | 2014 | 4618 | 0.060 |
Why?
|
p300-CBP Transcription Factors | 1 | 2006 | 150 | 0.060 |
Why?
|
Osmotic Pressure | 1 | 2005 | 137 | 0.060 |
Why?
|
Species Specificity | 1 | 2009 | 2406 | 0.060 |
Why?
|
Genomics | 1 | 2000 | 5828 | 0.060 |
Why?
|
Biological Transport | 1 | 2009 | 2080 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2658 | 0.060 |
Why?
|
Haplotypes | 2 | 2002 | 2715 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2003 | 1348 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 924 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 1998 | 6124 | 0.060 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13402 | 0.060 |
Why?
|
Directly Observed Therapy | 1 | 2004 | 139 | 0.060 |
Why?
|
Codon | 1 | 2006 | 597 | 0.060 |
Why?
|
Histone Acetyltransferases | 1 | 2006 | 335 | 0.060 |
Why?
|
Medication Adherence | 1 | 2015 | 2175 | 0.060 |
Why?
|
DNA Footprinting | 1 | 2003 | 97 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2018 | 64681 | 0.060 |
Why?
|
Models, Biological | 4 | 2004 | 9457 | 0.050 |
Why?
|
Aspartic Acid | 1 | 2006 | 574 | 0.050 |
Why?
|
Calcineurin | 2 | 1994 | 229 | 0.050 |
Why?
|
Chromosome Deletion | 2 | 1990 | 1386 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2012 | 2726 | 0.050 |
Why?
|
Clone Cells | 3 | 1996 | 1668 | 0.050 |
Why?
|
Transcription Initiation Site | 1 | 2003 | 187 | 0.050 |
Why?
|
Fixatives | 1 | 2003 | 90 | 0.050 |
Why?
|
Restriction Mapping | 1 | 2003 | 849 | 0.050 |
Why?
|
Plasmids | 2 | 2003 | 2261 | 0.050 |
Why?
|
Haplorhini | 1 | 2003 | 523 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2006 | 900 | 0.050 |
Why?
|
Early Growth Response Protein 1 | 1 | 2003 | 133 | 0.050 |
Why?
|
Adult | 12 | 2015 | 221119 | 0.050 |
Why?
|
Alkynes | 2 | 2014 | 320 | 0.050 |
Why?
|
Software | 1 | 2016 | 4431 | 0.050 |
Why?
|
Viral Load | 3 | 2012 | 3328 | 0.050 |
Why?
|
E1A-Associated p300 Protein | 1 | 2003 | 123 | 0.050 |
Why?
|
Cell Division | 2 | 2004 | 4451 | 0.050 |
Why?
|
Receptors, Steroid | 1 | 1983 | 155 | 0.050 |
Why?
|
Genes, Viral | 2 | 1995 | 649 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 3412 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2003 | 812 | 0.050 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 716 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
Cyclopropanes | 2 | 2014 | 432 | 0.050 |
Why?
|
Male | 14 | 2015 | 360693 | 0.050 |
Why?
|
Spleen | 2 | 2000 | 2290 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2000 | 1762 | 0.050 |
Why?
|
Mumps | 1 | 2002 | 71 | 0.050 |
Why?
|
Homicide | 1 | 1984 | 294 | 0.050 |
Why?
|
Peru | 1 | 2004 | 888 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2022 | 92 | 0.050 |
Why?
|
Caspase 1 | 1 | 2022 | 226 | 0.050 |
Why?
|
Formaldehyde | 1 | 2003 | 357 | 0.050 |
Why?
|
Receptors, Glucocorticoid | 1 | 1983 | 303 | 0.050 |
Why?
|
Luciferases | 1 | 2003 | 710 | 0.050 |
Why?
|
Female | 15 | 2015 | 392544 | 0.050 |
Why?
|
Receptors, KIR | 1 | 2001 | 110 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12474 | 0.050 |
Why?
|
HLA-C Antigens | 1 | 2001 | 141 | 0.050 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2000 | 69 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2006 | 1251 | 0.040 |
Why?
|
Genetic Markers | 2 | 2005 | 2599 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2002 | 360 | 0.040 |
Why?
|
Skin Tests | 1 | 2002 | 638 | 0.040 |
Why?
|
HIV | 1 | 2007 | 1581 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2002 | 324 | 0.040 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 1999 | 33 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2000 | 2426 | 0.040 |
Why?
|
DNA, Viral | 1 | 2006 | 2195 | 0.040 |
Why?
|
Lymphotoxin beta Receptor | 1 | 1999 | 25 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2009 | 3210 | 0.040 |
Why?
|
Hypersensitivity, Delayed | 1 | 2000 | 490 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2001 | 487 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2002 | 1250 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 1999 | 255 | 0.040 |
Why?
|
Passive Cutaneous Anaphylaxis | 1 | 1998 | 31 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2854 | 0.040 |
Why?
|
Food Supply | 1 | 2004 | 539 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2000 | 606 | 0.040 |
Why?
|
Cohort Studies | 4 | 2014 | 41496 | 0.040 |
Why?
|
Genetic Variation | 2 | 2006 | 6567 | 0.040 |
Why?
|
Alleles | 2 | 2001 | 6857 | 0.040 |
Why?
|
Protein Conformation | 1 | 2006 | 3933 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 3 | 1994 | 704 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 1981 | 836 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3430 | 0.040 |
Why?
|
Cell Degranulation | 1 | 1998 | 277 | 0.040 |
Why?
|
Liver | 3 | 2000 | 7514 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 1999 | 344 | 0.040 |
Why?
|
Disease Progression | 2 | 2006 | 13511 | 0.030 |
Why?
|
Inflammasomes | 1 | 2022 | 526 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1998 | 765 | 0.030 |
Why?
|
Receptors, IgE | 1 | 1998 | 375 | 0.030 |
Why?
|
G-Box Binding Factors | 1 | 1996 | 8 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 680 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2004 | 4190 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 1998 | 1301 | 0.030 |
Why?
|
Program Evaluation | 1 | 2004 | 2489 | 0.030 |
Why?
|
Hepatitis C | 1 | 2006 | 1579 | 0.030 |
Why?
|
Major Histocompatibility Complex | 1 | 1998 | 872 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3803 | 0.030 |
Why?
|
HIV Seropositivity | 1 | 2001 | 957 | 0.030 |
Why?
|
Protein Biosynthesis | 2 | 1993 | 2091 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1995 | 221 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1996 | 286 | 0.030 |
Why?
|
Drug Synergism | 1 | 1999 | 1756 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2005 | 790 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2001 | 1408 | 0.030 |
Why?
|
ras Proteins | 1 | 2000 | 1055 | 0.030 |
Why?
|
Leukemia, Myeloid | 1 | 2018 | 693 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 1240 | 0.030 |
Why?
|
Epitopes | 1 | 2001 | 2504 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2006 | 3446 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2006 | 22174 | 0.030 |
Why?
|
Ionomycin | 1 | 1993 | 110 | 0.030 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1994 | 317 | 0.030 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1995 | 355 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2016 | 834 | 0.030 |
Why?
|
Lung | 1 | 2012 | 9979 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 1998 | 1994 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1998 | 1435 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1996 | 1681 | 0.030 |
Why?
|
Receptor Aggregation | 1 | 1992 | 72 | 0.030 |
Why?
|
Recombinant Proteins | 3 | 1998 | 6504 | 0.030 |
Why?
|
Cycloheximide | 2 | 1991 | 343 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2006 | 3836 | 0.030 |
Why?
|
Virus Latency | 1 | 1995 | 354 | 0.020 |
Why?
|
Antibiotics, Antitubercular | 1 | 2012 | 99 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2016 | 1080 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2001 | 2194 | 0.020 |
Why?
|
Organ Specificity | 1 | 1996 | 1963 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2011 | 4851 | 0.020 |
Why?
|
Rural Population | 1 | 2002 | 2277 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2004 | 3410 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8003 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2006 | 3417 | 0.020 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 943 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 3726 | 0.020 |
Why?
|
Mast Cells | 1 | 1998 | 1392 | 0.020 |
Why?
|
Methylation | 1 | 1993 | 1070 | 0.020 |
Why?
|
RNA Caps | 1 | 1990 | 73 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 416 | 0.020 |
Why?
|
Interleukin-4 | 1 | 1994 | 1154 | 0.020 |
Why?
|
Time Factors | 2 | 2003 | 39957 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1867 | 0.020 |
Why?
|
2-Aminopurine | 1 | 1989 | 11 | 0.020 |
Why?
|
Phagocytes | 1 | 1991 | 294 | 0.020 |
Why?
|
Phosphorylation | 1 | 2000 | 8300 | 0.020 |
Why?
|
Ligands | 1 | 1996 | 3264 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 59221 | 0.020 |
Why?
|
Lymphocytes | 1 | 1996 | 2603 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2014 | 858 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1991 | 433 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 1991 | 748 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1901 | 0.020 |
Why?
|
Consensus Sequence | 1 | 2008 | 362 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2008 | 151 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29687 | 0.020 |
Why?
|
Genome, Human | 1 | 2000 | 4423 | 0.020 |
Why?
|
Middle Aged | 4 | 2006 | 220853 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 1996 | 4107 | 0.020 |
Why?
|
Lymphoma | 1 | 1996 | 1898 | 0.020 |
Why?
|
Dimerization | 1 | 2008 | 887 | 0.020 |
Why?
|
Reference Values | 1 | 1994 | 4921 | 0.020 |
Why?
|
Insulin | 1 | 1981 | 6588 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2003 | 16952 | 0.020 |
Why?
|
International Agencies | 1 | 2007 | 244 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 983 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1999 | 4935 | 0.020 |
Why?
|
Psychology | 1 | 1988 | 356 | 0.020 |
Why?
|
Physicians | 1 | 1984 | 4584 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 96 | 0.020 |
Why?
|
Genes, rev | 1 | 2005 | 13 | 0.020 |
Why?
|
Genes, vif | 1 | 2005 | 15 | 0.020 |
Why?
|
Genes, gag | 1 | 2005 | 55 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1990 | 4167 | 0.020 |
Why?
|
Human Rights | 1 | 1988 | 308 | 0.020 |
Why?
|
Bone Marrow Cells | 2 | 2005 | 2410 | 0.010 |
Why?
|
Medical History Taking | 1 | 1988 | 773 | 0.010 |
Why?
|
Adolescent | 2 | 2006 | 88298 | 0.010 |
Why?
|
Sex Offenses | 1 | 1988 | 352 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 2006 | 470 | 0.010 |
Why?
|
Biological Therapy | 1 | 2005 | 139 | 0.010 |
Why?
|
Guatemala | 1 | 1984 | 159 | 0.010 |
Why?
|
Craniocerebral Trauma | 1 | 1988 | 491 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1983 | 298 | 0.010 |
Why?
|
Calcium | 1 | 1996 | 5719 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2005 | 552 | 0.010 |
Why?
|
Lentivirus | 1 | 2005 | 508 | 0.010 |
Why?
|
Japan | 1 | 2006 | 1378 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39126 | 0.010 |
Why?
|
Genes, Lethal | 1 | 1981 | 223 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6486 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8998 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2380 | 0.010 |
Why?
|
Refugees | 1 | 1988 | 595 | 0.010 |
Why?
|
Th2 Cells | 1 | 2005 | 1071 | 0.010 |
Why?
|
Kinetics | 2 | 1991 | 6312 | 0.010 |
Why?
|
India | 1 | 2006 | 2287 | 0.010 |
Why?
|
Histamine Release | 1 | 1998 | 134 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2006 | 873 | 0.010 |
Why?
|
Politics | 1 | 1984 | 814 | 0.010 |
Why?
|
Acute Disease | 1 | 2007 | 7226 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6199 | 0.010 |
Why?
|
History, 20th Century | 1 | 1984 | 2765 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1981 | 2665 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14025 | 0.010 |
Why?
|
Child | 2 | 1998 | 80152 | 0.010 |
Why?
|
Dexamethasone | 1 | 1983 | 1945 | 0.010 |
Why?
|
Child, Preschool | 1 | 1998 | 42224 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1998 | 1751 | 0.010 |
Why?
|
Heterozygote | 1 | 1981 | 2778 | 0.010 |
Why?
|
Genes, fos | 1 | 1994 | 175 | 0.010 |
Why?
|
Fetus | 1 | 1981 | 1864 | 0.010 |
Why?
|
Pregnancy | 2 | 1988 | 29893 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2005 | 3048 | 0.010 |
Why?
|
Anisomycin | 1 | 1991 | 27 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24021 | 0.010 |
Why?
|
Cell Membrane | 1 | 1981 | 3661 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2005 | 3092 | 0.010 |
Why?
|
Cytosol | 1 | 1994 | 883 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54435 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 1988 | 4575 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 1545 | 0.010 |
Why?
|
Immunoblotting | 1 | 1991 | 1644 | 0.000 |
Why?
|
Interleukin-2 | 1 | 1994 | 1891 | 0.000 |
Why?
|
Aged | 1 | 1998 | 169288 | 0.000 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1994 | 2820 | 0.000 |
Why?
|
RNA, Viral | 1 | 1991 | 2839 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1991 | 4537 | 0.000 |
Why?
|